Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Novo Nordisk 12.087, Viking Therapeutics 0.
Novo Nordisk vs Viking Therapeutics: Revenue Comparison
Novo Nordisk (NVO) and Viking Therapeutics (VKTX) are peers in GLP-1. Novo Nordisk reported revenue of $12.1B as of Q2 2026, compared with $0 for Viking Therapeutics. Novo Nordisk leads on revenue.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Novo Nordisk, Viking Therapeutics.| Metric | Novo Nordisk | Viking Therapeutics |
|---|---|---|
| Market Cap | - | - |
| Revenue | $12.09B | $0 |
| Cost of Revenue | $2.63B | $0 |
| Gross Profit | $9.45B | $0 |
| Operating Income | $4.17B | $-133.00M |
| Net Income | $3.23B | $-128.00M |
| R&D Expense | $2.74B | $116.00M |
| Earnings Per Share | $0.73 | -$1.1 |
| Gross Margin | 78.2% | - |
| Operating Margin | 34.5% | - |
| Net Profit Margin | 26.7% | - |
| Free Cash Flow | $6.53B | $-125.00M |
| Cumulative Free Cash Flow | $107.39B | $-872.00M |
| Operating Cash Flow | $8.50B | $-125.00M |
| Cash & Equivalents | $6.85B | $126.00M |